Citations

Showing 10 of 108104 citations.

Clincal Note: Unusual EEG Referrals
Klass, Donald W., Westmoreland, Barbara F.

Mayo Clinic

American Journal of Electroneurodiagnostic Technology | October 10, 2018 | Volume: 41 | Issue: 3 | Pages: 209-210

10.1080/1086508x.2001.11079349 Get It

Focal Periodic Myogenic Artifact Affecting the EEG
Mosewich, Russell K., McManis, Philip G., Klass, Donald W.

Mayo Clinic

American Journal of Electroneurodiagnostic Technology | October 10, 2018 | Volume: 37 | Issue: 3 | Pages: 196-207

10.1080/1086508x.1997.11079188 Get It

The Sympathetic Skin Response in the EEG
Westmoreland, Barbara F., Donat, Jane F.

Mayo Clinic

American Journal of Electroneurodiagnostic Technology | October 10, 2018 | Volume: 38 | Issue: 3 | Pages: 164-173

10.1080/1086508x.1998.11079226 Get It

Age is a critical determinant in recovery from multiple sclerosis relapses
Conway, Brittani L., Zeydan, Burcu , Uygunoğlu, Uğur , Novotná, Martina, Sıva, Aksel , Pittock, Sean J. , Atkinson, Elizabeth J. , Rodriguez, Moses , Kantarci, Orhun H. , Pittock, S J , Rodriguez, Moses , Siva, Aksel , Zeydan, Burcu

Mayo Clinic

Multiple Sclerosis Journal | October 10, 2018 | Volume: 25 | Issue: 13 | Pages: 1754-1763

10.1177/1352458518800815 | PMID 30303037 Get It

Objective: To evaluate the impact of age on recovery from multiple sclerosis relapses. Background: Increasing disability in multiple sclerosis is a consequence of progressive disease and incomplete relapse recovery. Methods: The first and last-ever relapse data (357 relapses in 193 patients) from the Olmsted County population-based multiple sclerosis cohort were systematically reviewed for age, fulminance, location (optic nerve, brainstem/cerebellar, spinal cord), peak deficit, and maximum recovery. Three different relapse-outcome measures were studied both as paired analyses and as an overall group effect: change from peak deficit to maximum recovery in raw functional system score related to the relapse (ΔFSS), a previously published FSS-based relapse-impact model, and change from peak deficit to maximum recovery in Extended Disability Status Scale (ΔEDSS) score. Results: Older age was linearly associated with worse recovery in the ΔFSS outcome ( p = 0.002), ΔEDSS outcome ( p < 0.001), and the FSS-based relapse-impact model ( p < 0.001). A multivariate analysis of ΔFSS outcome linked poor recovery to older age ( p = 0.015), relapse location (transverse myelitis or brainstem/cerebellar syndrome; p < 0.001), and relapse fulminance ( p = 0.004). Conclusion: Multiple sclerosis-relapse recovery declines in a linear fashion with increased age, which should be considered when making treatment decisions.
A Glossary of Terms Used for PLEDs (Periodic Lateralized Epileptiform Discharges) and Related EEG Patterns
Sazgar, Mona , Westmoreland, Barbara F., Sharbrough, Frank W., Klass, Donald W.

Mayo Clinic

American Journal of Electroneurodiagnostic Technology | October 10, 2018 | Volume: 43 | Issue: 3 | Pages: 185-190

10.1080/1086508x.2003.11079435 Get It

Resuscitation Artifacts during Electroencephalography
Schäuble, Barbara, Klass, Donald W., Westmoreland, Barbara F.

Mayo Clinic

American Journal of Electroneurodiagnostic Technology | October 10, 2018 | Volume: 42 | Issue: 1 | Pages: 16-21

10.1080/1086508x.2002.11079371 Get It

Recurrent Genomic Alterations in Soft Tissue Perineuriomas
Carter, Jodi M. , Wu, Yanhong , Blessing, Melissa M. , Folpe, Andrew L. , Thorland, Erik C., Spinner, Robert J. , Jentoft, Mark E. , Baheti, Saurabh , Niu, Zhiyv , Mauermann, Michelle L. , Mauermann, Michelle L , Niu, Zhiyv , Wang, Chen , Klein, Christopher J. , Carter, Jodi

Mayo Clinic

American Journal of Surgical Pathology | October 10, 2018 | Volume: 42 | Issue: 12 | Pages: 1708-1714

10.1097/pas.0000000000001169 | PMID 30303818 Get It

Perineuriomas are rare nerve sheath tumors, divided into intraneural and extraneural (soft tissue) types. Intraneural perineuriomas frequently contain TRAF7 mutations, and rarely, chr22q12 deletions. While chr22q losses can occur in soft tissue perineuriomas, comprehensive high-resolution molecular profiling has not been reported in these tumors and TRAF7 status is unknown. We used whole-exome sequencing and OncoScan single nucleotide polymorphism (SNP) array to evaluate 14 soft tissue perineuriomas. Thirteen cases showed 2 or more chromosomal abnormalities, composed primarily of large deletions. Recurrent chr22q deletions, containing the NF2 locus (n=6) and the previously unreported finding of chr17q deletions, with the NF1 locus (n=4) were frequent events and were mutually exclusive in all but1 case. In addition, 5 cases had varying chr2 deletions; and 4 cases had chr6 deletions. A chr10 deletion (previously reported in the sclerosing variant of soft tissue perineurioma) was observed in one case and another case had chr7 chromothripsis as the sole chromosomal abnormality. No TRAF7 mutations or alterations were identified in any case and no other evaluated gene (MAF<0.0001) had recurrent, deleterious mutations in >2 cases. The molecular genetic profiles showed no association with patient sex, age, tumoral histology or anatomic site. OncoScan SNP array analysis was performed on 10 cases and showed high concordance with the whole exome data, validating the large-scale deletions, duplications, and chr7 chromothripsis findings. In soft tissue perineuriomas, recurrent 22q12 deletions (with NF2) and 17q11 deletions (with NF1) appear to be mutually exclusive events, and alterations in NF1 or NF2 likely contribute to perineurioma pathogenesis, similar to other nerve sheath tumors. Moreover, the lack of TRAF7 mutations in soft tissue perineuriomas indicates divergent pathogenetic mechanisms from those of intraneural perineuriomas.
Several household chemical exposures are associated with pediatric‐onset multiple sclerosis
Mar, Soe , Liang, Shannon , Waltz, Michael , Casper, T. Charles , Greenberg, Benjamin , Rodriguez, Moses , Aaen, Gregory , Belman, Anita , Barcellos, Lisa F. , Rose, John , Gorman, Mark , Candee, Meghan , Chitnis, Tanjua, Harris, Yolanda, Kahn, Ilana , Roalsted, Shelly, Hart, Janace, Lotze, Timothy , Moodley, Manikum , Ness, Jayne , Rubin, Jennifer , Schreiner, Teri , Tillema, Jan‐Mendelt , Krupp, Lauren , Krupp, Lauren , Rodriguez, Moses , Greenberg, Benjamin M , Goyal, Manu S. , Weinstock‐Guttman, Bianca , Benson, Leslie , Rensel, Mary R. , Schreiner, Teri , Waldman, Amy , Graves, Jennifer , Waubant, Emmanuelle L. , Rubin, Jennifer P

Mayo Clinic

Annals of Clinical and Translational Neurology | October 10, 2018 | Volume: 5 | Issue: 12 | Pages: 1513-1521

10.1002/acn3.663 | PMID 30564618 Get It

AbstractBackgroundThere is limited information about the potential associations of multiple sclerosis (MS) and commonly used household chemicals.MethodsWe performed a case‐control study of exposures to common household chemicals during childhood in children with MS and healthy pediatric controls. Exposures to household products were collected from a comprehensive questionnaire (http://www.usnpmsc.org/Documents/EnvironmentalAssessment.pdf) completed by parents at the time of enrollment in the study. Cases included children diagnosed with MS or clinically isolated syndrome with at least two silent T2 bright lesions on MRI, recruited within 4 years of disease onset from 16 pediatric MS clinics in the USA. Multivariate analyses using logistic regression were adjusted for possible confounders including age, sex, race, ethnicity, mother's highest level of education, and urban versus rural living.ResultsQuestionnaire responses to household chemicals were available for 312 eligible cases (median age 15.7 years, 63% girls) and 490 healthy controls (median age 15.0, 57% girls). Exposure to rodenticides (odds ratio [OR] 2.10, 95% confidence interval [CI] 1.35–3.26, P ≤ 0.001), weed control agents (OR 1.99, 95% CI 1.36–2.92, P ≤ 0.001) and products for plant/tree disease control (OR 2.72, 95% CI 1.54–4.82, P ≤ 0.001) anytime during childhood were associated with an increased risk for pediatric‐onset MS in adjusted and multiple comparisons analyses.ConclusionsOur findings suggest that exposure to specific household chemicals during early childhood is associated with the risk of developing pediatric‐onset MS. Future studies are needed to elucidate a causal relationship and the exact agents involved.
Intra-abdominal Sepsis After Ileocolic Resection in Crohn’s Disease: The Role of Combination Immunosuppression
McKenna, Nicholas P. , Habermann, Elizabeth B. , Glasgow, Amy E. , Dozois, Eric J. , Glasgow, Amy E. , Habermann, Elizabeth , McKenna, Nicholas P , Lightner, Amy L. , Glasgow, Amy E

Mayo Clinic

Diseases of the Colon & Rectum | October 10, 2018 | Volume: 61 | Issue: 12 | Pages: 1393-1402

10.1097/dcr.0000000000001153 | PMID 30303885 Get It

BACKGROUND: Intra-abdominal sepsis complicates <10% of ileocolic resections for Crohn’s disease, but the impact of combination immunosuppression and repeat resection on its development remains unknown. OBJECTIVE: The purpose of this study was to determine risk factors for intra-abdominal sepsis after ileocolic resection, specifically examining the role of combination immunosuppression and repeat intestinal resection. DESIGN: This was a retrospective review of patient records from 2007 to 2017. SETTINGS: The study was conducted at a single-institution IBD tertiary referral center. PATIENTS: Patients with a diagnosis of Crohn’s disease who were undergoing ileocolic resection with primary anastomosis were included. Diverted patients were excluded. MAIN OUTCOME MEASURES: Preoperative and intraoperative variables, including preoperative immunosuppressive regimens and previous intestinal resection, were evaluated as potential risk factors for intra-abdominal sepsis. RESULTS: A total of 621 patients (55% women) underwent ileocolic resection for Crohn’s disease; 393 (63%) were first-time resections. The rate of 30-day intra-abdominal sepsis was 8% (n = 50). On univariate analysis, triple immunosuppression (combination of a corticosteroid, immunomodulator, and biological) and previous intestinal resection were significantly associated with intra-abdominal sepsis. Both risk factors remained significant on multivariable analysis (OR for triple immunosuppression (vs none) = 3.53 (95% CI, 1.27–9.84); previous intestinal resection OR = 2.27 (95% CI, 1.25–4.13)). A significant trend was seen between an increasing number of these risk factors (triple immunosuppression and previous intestinal resection) and rate of intra-abdominal sepsis (5%, 12%, and 22% for 0, 1, and 2 risk factors; p < 0.01). A trend was observed between increasing number of previous intestinal resections and the rate of intra-abdominal sepsis (p < 0.01). LIMITATIONS: This study is limited by its single-institution tertiary referral center scope. CONCLUSIONS: Combination immunosuppression and previous intestinal resection were both associated with the development of intra-abdominal sepsis. In light of these results, surgeons should consider the effects of combination immunosuppression and a history of previous intestinal resection, in addition to other risk factors, when deciding which patients warrant temporary intestinal diversion. See Video Abstract at http://links.lww.com/DCR/A664.
New daily persistent headache (NDPH) triggered by a single Valsalva event: A case series
Rozen, Todd D.

Mayo Clinic

Cephalalgia | October 10, 2018 | Volume: 39 | Issue: 6 | Pages: 785-791

10.1177/0333102418806869 | PMID 30301379 Get It

Objective To describe a new subtype of new daily persistent headache that is triggered by a single Valsalva event. Methods A case series of patients was evaluated in an academic headache clinic over a 3-year time period. Results A total of seven patients (four female and three male) were diagnosed with this new subtype of new daily persistent headache. The headaches all began after a single Valsalva event. Average age at time of headache onset was 41 years (males: 39 years; females: 43 years) with an age range of 20–62 years. All patients developed their syndrome during the months of September to February with November and February being the most cited months (5/7 patients). Immediate worsening in the Trendelenburg position occurred in all patients and appeared to be an almost diagnostic test for the syndrome. No patient had papilledema on funduscopic exam. Five out of seven patients had no prior headache history including cough, exercise or migraine. Four of seven patients were of normal weight, while one was overweight and two were obese. A crowded posterior fossa was identified in five of seven patients on brain MRI. On cerebrospinal fluid pressure/volume lowering medication (acetazolamide, indomethacin and/or spironolactone), five out of seven patients achieved 90% plus improvement in headache frequency while three patients became pain free. Three patients were able to taper off medication without headache recurrence. Conclusion New daily persistent headache after a single Valsalva event appears to be a unique subtype of new daily persistent headache that is responsive to cerebrospinal fluid pressure/volume lowering medications. An abnormal reset of cerebrospinal fluid pressure/intracranial pressure to an elevated state is the presumed pathogenesis and may relate to the patient's baseline neuroanatomy of a crowded posterior fossa. There appears to be a circadian periodicity to the onset of the syndrome. Worsening in the Trendelenburg position is a probable diagnostic test. Defining new daily persistent headache subtypes by triggering event appears to be making a positive inroad in the understanding of this condition and helps present new effective therapies.